CONMED Corp. buy JPMorgan Chase & Co.
Start price
01.02.24
/
50%
€77.50
Target price
01.02.25
€106.18
Performance (%)
-10.97%
End price
02.02.25
€69.00
Summary
This prediction ended on 02.02.25 with a price of €69.00. The price of CONMED Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.97%. Dividends of €0.74 are taken into consideration when calculating the performance. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CONMED Corp. | 2.732% | 2.732% | -12.558% |
| iShares Core DAX® | 3,90 % | 2,67 % | 5,69 % |
| iShares Nasdaq 100 | -2,60 % | -7,93 % | 19,50 % |
| iShares Nikkei 225® | -0,54 % | -9,75 % | 46,05 % |
| iShares S&P 500 | -0,88 % | -1,49 % | 16,91 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread CONMED Corp. diskutieren
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at JPMorgan Chase & Co. from $135.00 to $115.00. They now have an "overweight" rating on the stock.
Ratings data for CNMD provided by MarketBeat
In the thread Trading CONMED Corp.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten